Clinical Trial Update: Carmustine Plus O6-benzylguanine in Treating Patients With Recurrent or Progressive Glioma [Phase 2]

View source ↗

Summary

A completed Phase 2 clinical trial evaluating the combination of Carmustine plus O6-benzylguanine in patients with recurrent or progressive glioma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioma

Drugs mentioned

• Carmustine (carmustine)
• O6-Benzylguanine (O6-Benzylguanine)

Snippet

Sponsor: Duke University | Conditions: Brain and Central Nervous System Tumors | Phase 2 | Status: COMPLETED